GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genxone SA (WAR:GX1) » Definitions » Price-to-Free-Cash-Flow

Genxone (WAR:GX1) Price-to-Free-Cash-Flow : N/A (As of May. 21, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Genxone Price-to-Free-Cash-Flow?

As of today (2025-05-21), Genxone's share price is zł6.14. Genxone's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was zł-0.57. Hence, Genxone's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Genxone's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 7 years, Genxone's highest Price-to-Free-Cash-Flow Ratio was 56.51. The lowest was 4.44. And the median was 9.43.

WAR:GX1's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.09
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Genxone's Free Cash Flow per Share for the three months ended in Dec. 2024 was zł-0.11. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was zł-0.57.

During the past 7 years, Genxone's highest 3-Year average Free Cash Flow per Share Growth Rate was 59.80% per year. The lowest was 59.80% per year. And the median was 59.80% per year.


Genxone Price-to-Free-Cash-Flow Historical Data

The historical data trend for Genxone's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genxone Price-to-Free-Cash-Flow Chart

Genxone Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial 29.80 6.63 - - -

Genxone Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Genxone's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Genxone's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genxone's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genxone's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Genxone's Price-to-Free-Cash-Flow falls into.


;
;

Genxone Price-to-Free-Cash-Flow Calculation

Genxone's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=6.14/-0.569
=N/A

Genxone's Share Price of today is zł6.14.
Genxone's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.57.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Genxone  (WAR:GX1) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Genxone Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Genxone's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Genxone Business Description

Industry
Traded in Other Exchanges
N/A
Address
ul. Kobaltowa 6, Zlotniki, Suchy Las, POL, 62-002
Genxone SA is a biotechnology company that applies nanopore sequencing technology (third-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. It specializes in developing new products and solutions based on the latest technologies of nucleic acid sequencing. The company's services include NANOPORE SEQUENCING that includes Whole Genome Sequencing, Bespoke Analysis, Metagenome Sequencing, Bioinformatic Analysis, 16S and/or ITS Gene Sequencing, and RNA Sequencing; and DIAGNOSTIC TESTS that includes Gastrointestinal Infections Panel, Respiratory Infections Panel, Urogenital Infection Panel, and Nervous System Infection Panel.

Genxone Headlines

No Headlines